RWE of Brentuximab Vedotin Consolidation in Patients With RR HL Who Receive Salvage Chemotherapy and ASCT

Clinical trial NCT04776265 · UNKNOWN

Trial details

NCT number: NCT04776265
Sponsor: Grupo Argentino de Tratamiento de la Leucemia Aguda
Status: UNKNOWN
Study type: OBSERVATIONAL

Hodgkin Lymphoma, Adult Relapsed Hodgkin's Disease, Adult Refractory Hodgkin Lymphoma

Start date: 2021-06-01
Primary completion: 2024-03-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.